Monash receives $17.5m to establish Victoria’s Health Innovation Centre

Professor Stephen Nicholls, The lead of HeartLabs and Director of Monash University’s Victorian Heart Institute

Monash University will establish Victoria’s Health Innovation Centre including a flagship cardiovascular research accelerator, HeartLabs and a new focal point for clinical trials to create high-value jobs, intellectual property, start-ups, attract and nurture new clinical trials.

Enabled by $17.5m in Victorian Higher Education State Investment Fund (VHESIF), the Centre will be housed in the Monash Technology Precinct and networked across the state.

HeartLabs to build Victorian Heart Institute

HeartLabs will translate and commercialise clinical research, cardiac technology, models of care, drug discovery, and biomedical engineering.

The lead of HeartLabs and Director of Monash University’s Victorian Heart Institute (VHI), Professor Stephen Nicholls expressed his delight and excitement.

“HeartLabs will house business development groups and industry partners as anchor tenants, accelerating new health and clinical innovations and attract global investment to Victoria.”

“Its critical to allow the VHI to turn its discoveries into real solutions for the community.”

The Health Innovation Centre will provide clinical trials sponsors, investors and partners with access to expertise in the design and delivery of global clinical trials with a single, virtual front door to attract, scale and streamline multi-site, industry-sponsored clinical trials.

Comments on HeartLabs’ Victorian Heart Institute

The lead of the Centre’s clinical trials, Professor Sophia Zoungas said, “The Centre will have a virtual clinical trials network connecting to Alfred Health, Eastern Health, Monash Health, Peninsula Health, Cabrini Health and Epworth HealthCare, and the Victorian Heart Hospital.

“Monash University has advanced bio-statistical expertise and extensive network of public and private hospitals, primary care, rehabilitation, aged care and community health providers.”

“This will enable us to support companies and the health system with trials to provide answers to treatment questions faster and with fewer patients than conventional randomised trials.”

HeartLabs complements the University’s current projects including the VHH and VHI.

Due to open in 2022 in close proximity to the VHH, HeartLabs will have access to research acceleration activities relating to translation and commercialisation outcomes, driving discoveries from the VHI and other medical research departments, centres and institutes.

Professor Margaret Gardner AC said, “Monash University is delighted to receive $17.5 million through the VHESIF to establish Victoria’s Health Innovation Centre at the heart of the state’s largest innovation and employment ecosystem outside Melbourne’s CBD.”

“This funding will enable Monash to deliver innovation in biotechnology, pharmaceutical research, development for cardiovascular disease with new products and services for better cardiovascular and other health outcomes, including access to medicines in trials.”

This follows the funding allocations through the VHESIF for its Safe and Equal Work, Access to Justice programs, smart manufacturing, research and development commercialisation.